Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays

Kazuki Inamori, Motoki Kyo, Kazuki Matsukawa, Yusuke Inoue, Tatsuhiko Sonoda, Takeshi Mori, Takuro Niidome, Yoshiki Katayama

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

We describe a label-free method for the kinase inhibition assay toward discovery of kinase inhibitors. The surface plasmon resonance (SPR) imaging analysis using zinc(II) compound was adopted on the on-chip phosphorylation analysis. In this study, following three subjects were focused: (1) to monitor the inhibition of three inhibitors supporting by their specific inhibition mechanisms, (2) to quantify the inhibitory activities, and (3) to prove the reliability of the obtained 50% inhibition concentration (IC50) value. First, the inhibitory activities of Amide 5-24, H-89 and Gö6983 on PKA and PKCδ were determined, and specific inhibitions for two kinases could be observed quantitatively. Second, the inhibition curves of Amide 5-24, Amide 14-22 and H-89 were obtained, and the results supported the two previous reports: (1) the inhibition efficiency of Amide 5-24 was much higher than that of Amide 14-22, and (2) the inhibitory activity of H-89 followed ATP-binding site blocking mechanism. Last, the obtained IC50 values by the SPR imaging were almost corresponded to those by the solution assay, although on-chip phosphorylation efficiency was low (approximately 12%). In conclusion, validation of the on-chip phosphorylation analysis for kinase inhibitors was achieved. This label-free method might be applied for discovery of kinase inhibitors.

元の言語英語
ページ(範囲)179-185
ページ数7
ジャーナルBioSystems
97
発行部数3
DOI
出版物ステータス出版済み - 9 1 2009

Fingerprint

Phosphorylation
Amides
Inhibitor
Screening
Labels
Assays
Chip
Phosphotransferases
Surface Plasmon Resonance
Surface plasmon resonance
Inhibitory Concentration 50
Surface Plasmon
Zinc Compounds
Imaging techniques
Adenosinetriphosphate
Binding sites
Imaging
Protein Kinase C
Zinc
Adenosine Triphosphate

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Applied Mathematics
  • Modelling and Simulation
  • Statistics and Probability

これを引用

Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays. / Inamori, Kazuki; Kyo, Motoki; Matsukawa, Kazuki; Inoue, Yusuke; Sonoda, Tatsuhiko; Mori, Takeshi; Niidome, Takuro; Katayama, Yoshiki.

:: BioSystems, 巻 97, 番号 3, 01.09.2009, p. 179-185.

研究成果: ジャーナルへの寄稿記事

Inamori, Kazuki ; Kyo, Motoki ; Matsukawa, Kazuki ; Inoue, Yusuke ; Sonoda, Tatsuhiko ; Mori, Takeshi ; Niidome, Takuro ; Katayama, Yoshiki. / Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays. :: BioSystems. 2009 ; 巻 97, 番号 3. pp. 179-185.
@article{7a00ac1d6d104f6c9d6e496dede68eeb,
title = "Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays",
abstract = "We describe a label-free method for the kinase inhibition assay toward discovery of kinase inhibitors. The surface plasmon resonance (SPR) imaging analysis using zinc(II) compound was adopted on the on-chip phosphorylation analysis. In this study, following three subjects were focused: (1) to monitor the inhibition of three inhibitors supporting by their specific inhibition mechanisms, (2) to quantify the inhibitory activities, and (3) to prove the reliability of the obtained 50{\%} inhibition concentration (IC50) value. First, the inhibitory activities of Amide 5-24, H-89 and G{\"o}6983 on PKA and PKCδ were determined, and specific inhibitions for two kinases could be observed quantitatively. Second, the inhibition curves of Amide 5-24, Amide 14-22 and H-89 were obtained, and the results supported the two previous reports: (1) the inhibition efficiency of Amide 5-24 was much higher than that of Amide 14-22, and (2) the inhibitory activity of H-89 followed ATP-binding site blocking mechanism. Last, the obtained IC50 values by the SPR imaging were almost corresponded to those by the solution assay, although on-chip phosphorylation efficiency was low (approximately 12{\%}). In conclusion, validation of the on-chip phosphorylation analysis for kinase inhibitors was achieved. This label-free method might be applied for discovery of kinase inhibitors.",
author = "Kazuki Inamori and Motoki Kyo and Kazuki Matsukawa and Yusuke Inoue and Tatsuhiko Sonoda and Takeshi Mori and Takuro Niidome and Yoshiki Katayama",
year = "2009",
month = "9",
day = "1",
doi = "10.1016/j.biosystems.2009.04.007",
language = "English",
volume = "97",
pages = "179--185",
journal = "BioSystems",
issn = "0303-2647",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Establishment of screening system toward discovery of kinase inhibitors using label-free on-chip phosphorylation assays

AU - Inamori, Kazuki

AU - Kyo, Motoki

AU - Matsukawa, Kazuki

AU - Inoue, Yusuke

AU - Sonoda, Tatsuhiko

AU - Mori, Takeshi

AU - Niidome, Takuro

AU - Katayama, Yoshiki

PY - 2009/9/1

Y1 - 2009/9/1

N2 - We describe a label-free method for the kinase inhibition assay toward discovery of kinase inhibitors. The surface plasmon resonance (SPR) imaging analysis using zinc(II) compound was adopted on the on-chip phosphorylation analysis. In this study, following three subjects were focused: (1) to monitor the inhibition of three inhibitors supporting by their specific inhibition mechanisms, (2) to quantify the inhibitory activities, and (3) to prove the reliability of the obtained 50% inhibition concentration (IC50) value. First, the inhibitory activities of Amide 5-24, H-89 and Gö6983 on PKA and PKCδ were determined, and specific inhibitions for two kinases could be observed quantitatively. Second, the inhibition curves of Amide 5-24, Amide 14-22 and H-89 were obtained, and the results supported the two previous reports: (1) the inhibition efficiency of Amide 5-24 was much higher than that of Amide 14-22, and (2) the inhibitory activity of H-89 followed ATP-binding site blocking mechanism. Last, the obtained IC50 values by the SPR imaging were almost corresponded to those by the solution assay, although on-chip phosphorylation efficiency was low (approximately 12%). In conclusion, validation of the on-chip phosphorylation analysis for kinase inhibitors was achieved. This label-free method might be applied for discovery of kinase inhibitors.

AB - We describe a label-free method for the kinase inhibition assay toward discovery of kinase inhibitors. The surface plasmon resonance (SPR) imaging analysis using zinc(II) compound was adopted on the on-chip phosphorylation analysis. In this study, following three subjects were focused: (1) to monitor the inhibition of three inhibitors supporting by their specific inhibition mechanisms, (2) to quantify the inhibitory activities, and (3) to prove the reliability of the obtained 50% inhibition concentration (IC50) value. First, the inhibitory activities of Amide 5-24, H-89 and Gö6983 on PKA and PKCδ were determined, and specific inhibitions for two kinases could be observed quantitatively. Second, the inhibition curves of Amide 5-24, Amide 14-22 and H-89 were obtained, and the results supported the two previous reports: (1) the inhibition efficiency of Amide 5-24 was much higher than that of Amide 14-22, and (2) the inhibitory activity of H-89 followed ATP-binding site blocking mechanism. Last, the obtained IC50 values by the SPR imaging were almost corresponded to those by the solution assay, although on-chip phosphorylation efficiency was low (approximately 12%). In conclusion, validation of the on-chip phosphorylation analysis for kinase inhibitors was achieved. This label-free method might be applied for discovery of kinase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=67651147969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651147969&partnerID=8YFLogxK

U2 - 10.1016/j.biosystems.2009.04.007

DO - 10.1016/j.biosystems.2009.04.007

M3 - Article

C2 - 19422876

AN - SCOPUS:67651147969

VL - 97

SP - 179

EP - 185

JO - BioSystems

JF - BioSystems

SN - 0303-2647

IS - 3

ER -